Savara Inc Adjustments to Additional Paid in Capital, Warrant Issued
Savara Inc (SVRA) reported Adjustments to Additional Paid in Capital, Warrant Issued of $29.00 thousand for the 12-month period ending 2020-12-31, per its 10-K filed 2022-03-30.
Discontinued › Shareholders' Equity › Adjustments to Additional Paid in Capital
us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued · last filed 2022-03-30
- Savara Inc adjustments to additional paid in capital, warrant issued for the quarter ending 2020-03-31 was $28.00K.
- Savara Inc adjustments to additional paid in capital, warrant issued for the quarter ending 2017-12-31 was $0.00.
- Savara Inc adjustments to additional paid in capital, warrant issued for the quarter ending 2017-09-30 was $0.00.
- Savara Inc adjustments to additional paid in capital, warrant issued for fiscal 2020 was $29.00K.
- Savara Inc adjustments to additional paid in capital, warrant issued for fiscal 2018 was $78.00K, a 78.27% decline from fiscal 2017.
- Savara Inc adjustments to additional paid in capital, warrant issued for fiscal 2017 was $359.00K, a 1280.77% increase from fiscal 2016.
- Savara Inc adjustments to additional paid in capital, warrant issued for fiscal 2016 was $26.00K, a 93.37% decline from fiscal 2015.
| Period end | Adjustments to Additional Paid in Capital, Warrant Issued 3 month | Adjustments to Additional Paid in Capital, Warrant Issued 6 month | Adjustments to Additional Paid in Capital, Warrant Issued 9 month | Adjustments to Additional Paid in Capital, Warrant Issued 12 month |
|---|---|---|---|---|
| 2020-12-31 | $29.00K 10-K · filed 2022-03-30 | |||
| 2020-03-31 | $28.00K 10-Q · filed 2021-11-12 | |||
| 2018-12-31 | $78.00K 10-K · filed 2020-03-12 | |||
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-13 | $0.00 derived: sum of 2 quarters · filed 2019-03-13 | $359.00K 10-K · filed 2019-03-13 | |
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-08 | $359.00K 10-Q · filed 2017-11-08 | ||
| 2017-06-30 | $359.00K 10-Q · filed 2017-08-09 | |||
| 2016-12-31 | $26.00K 10-K · filed 2017-03-06 | |||
| 2015-12-31 | $392.00K 10-K · filed 2017-03-06 | |||
| 2004-12-31 | $86.38K 10-K · filed 2014-03-26 | |||
| 2001-12-31 | $450.00K 10-K · filed 2014-03-26 | |||
| 1999-12-31 | $212.00K 10-K · filed 2014-03-26 | |||
| 1998-12-31 | $260.00K 10-K · filed 2014-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| MANNKIND CORP (MNKD) | United States | $1.058B | -30.41 |
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 | |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B |